Translational scientists from around the globe will assemble in Huntington Beach this October for the 7th International Symposium on Translational Research in Oncology. The program, developed by co-chairs Dennis J. Slamon M.D., Ph.D., and John Crown M.D., M.P.H., includes discussions on the latest translational research developments, to improve the clinical outcomes for cancer patients.
The translational component is significant to the survival of patients; translating the latest breakthroughs in the laboratory efficiently to a cutting edge treatment plan for patients.
Renato Baserga, M.D., Professor, Cancer Biology and Vice Chairman for Research at the Kimmel Cancer Center at Jefferson, is a keynote speaker at the event. Dr. Baserga’s presentation is entitled “The IGFR Signaling Pathway as a Novel Therapeutic Target”. Dr. Baserga is internationally renowned for his discovery that IGFR governs aberrant cell growth – forming the basis for current clinical targeting strategies.
The 7th International Symposium on Translational Research in Oncology, jointly sponsored by the Postgraduate Institute for Medicine and Clinical Care Options LLC, will be held at the Hyatt Regency Huntington Beach in California, from October 16-19, 2008. To register online click here.